Euro
USD
British Pound
NULL
Product Description
A convenient set consisting of seven inhibitors useful for the study of MAP Kinase signaling pathway. The seven inhibitors are: 1 mg of PD 184352 (Cat. No. 1585-1), 5 mg of PD 98059 (Cat. No. 1666-5), 1 mg of SB 203580 (Cat. No. 1712-1), 25 mg of Sorafenib (Cat. No. 1594-25), 5 mg of SP 600125 (Cat. No. 1669-5), 5 mg of U0126 (Cat. No. 1668-5), and 1 mg of ZM 336372 (Cat. No. 1789-1).
PathwayReady™ MAP Kinase Signaling Inhibitor Panel is a convenient set consisting of seven inhibitors useful for the study of MAP Kinase signaling pathway. The seven inhibitors are: 1 mg of PD 184352 (Cat. No. 1585-1), 5 mg of PD 98059 (Cat. No. 1666-5), 1 mg of SB 203580 (Cat. No. 1712-1), 25 mg of Sorafenib (Cat. No. 1594-25), 5 mg of SP 600125 (Cat. No. 1669-5), 5 mg of U0126 (Cat. No. 1668-5), and 1 mg of ZM 336372 (Cat. No. 1789-1).
Biovision | K862 | PathwayReady™ MAP Kinase Signaling Inhibitor Panel DataSheet
Alternate Name/Synonyms: MAP Kinase Signaling Inhibitor Panel, PathwayReady™
Appearance: Lyophilized solids
Formulation: N/A
CAS Number: See under the individual product
Structure Available?: See under the individual product
Peptide sequence: N/A
Salt Form: No
Molecular Formula: See under the individual product
Molecular Weight: See under the individual product
Cell-Permeable?: Yes
Purity: ≥95% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A MAP kinase pathway inhibitors set
MDL Number: N/A
PubChem CID: N/A
SMILES: N/A
InChi: N/A
InChi Key: N/A
